These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35297004)

  • 1. Pregnancy, Fetal, and Infant Outcomes Following Maternal Exposure to Glatiramer Acetate During Pregnancy and Breastfeeding.
    Kaplan S; Zeygarnik M; Stern T
    Drug Saf; 2022 Apr; 45(4):345-357. PubMed ID: 35297004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregnancy and fetal outcomes following maternal exposure to glatiramer acetate in all three trimesters of pregnancy.
    Kaplan S; Zeygarnik M; Stern T; Hellwig K
    Eur J Neurol; 2023 Dec; 30(12):3890-3895. PubMed ID: 37565380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregnancy and fetal outcomes following paternal exposure to glatiramer acetate.
    Kaplan S; Dragut CF; Ghimpeteanu A
    Curr Med Res Opin; 2024 May; 40(5):821-825. PubMed ID: 38577712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glatiramer acetate during early pregnancy: A prospective cohort study.
    Herbstritt S; Langer-Gould A; Rockhoff M; Haghikia A; Queisser-Wahrendorf A; Gold R; Hellwig K
    Mult Scler; 2016 May; 22(6):810-6. PubMed ID: 26754804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric study.
    Giannini M; Portaccio E; Ghezzi A; Hakiki B; Pastò L; Razzolini L; Piscolla E; De Giglio L; Pozzilli C; Paolicelli D; Trojano M; Marrosu MG; Patti F; La Mantia L; Mancardi G; Solaro C; Totaro R; Tola MR; De Luca G; Lugaresi A; Moiola L; Martinelli V; Comi G; Amato MP
    BMC Neurol; 2012 Oct; 12():124. PubMed ID: 23088447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety evaluations of offspring breastfed by mothers receiving glatiramer acetate for relapsing multiple sclerosis.
    Ciplea AI; Kurzeja A; Thiel S; Haben S; Adamus E; Hellwig K
    Mult Scler Relat Disord; 2023 Jul; 75():104771. PubMed ID: 37245349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eighteen-month safety analysis of offspring breastfed by mothers receiving glatiramer acetate therapy for relapsing multiple sclerosis - COBRA study.
    Ciplea AI; Kurzeja A; Thiel S; Haben S; Alexander J; Adamus E; Hellwig K
    Mult Scler; 2022 Sep; 28(10):1641-1650. PubMed ID: 35362346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of potential breast milk exposure to IFN-β or glatiramer acetate: One-year infant outcomes.
    Ciplea AI; Langer-Gould A; Stahl A; Thiel S; Queisser-Wahrendorf A; Gold R; Hellwig K
    Neurol Neuroimmunol Neuroinflamm; 2020 Jul; 7(4):. PubMed ID: 32434802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the postmarketing experience of risperidone use during pregnancy: pregnancy and neonatal outcomes.
    Coppola D; Russo LJ; Kwarta RF; Varughese R; Schmider J
    Drug Saf; 2007; 30(3):247-64. PubMed ID: 17343431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregnancy Outcomes from the Branded Glatiramer Acetate Pregnancy Database.
    Sandberg-Wollheim M; Neudorfer O; Grinspan A; Weinstock-Guttman B; Haas J; Izquierdo G; Riley C; Ross AP; Baruch P; Drillman T; Coyle PK
    Int J MS Care; 2018; 20(1):9-14. PubMed ID: 29507538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnancy outcomes following exposure to abatacept during pregnancy.
    Kumar M; Ray L; Vemuri S; Simon TA
    Semin Arthritis Rheum; 2015 Dec; 45(3):351-6. PubMed ID: 26210783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregnancy Outcomes in Patients Exposed to OnabotulinumtoxinA Treatment: A Cumulative 29-Year Safety Update.
    Brin MF; Kirby RS; Slavotinek A; Adams AM; Parker L; Ukah A; Radulian L; Elmore MRP; Yedigarova L; Yushmanova I
    Neurology; 2023 Jul; 101(2):e103-e113. PubMed ID: 37137724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy Outcomes in Patients Treated with Upadacitinib: Analysis of Data from Clinical Trials and Postmarketing Reports.
    Mahadevan U; Levy G; Gensler L; Ali M; Lacerda AP; Wegrzyn L; Palac H; Bhutani-Jacques T; Long M; Clowse MEB; Kimball AB; Chambers C; Scialli AR
    Drug Saf; 2024 Oct; 47(10):1039-1049. PubMed ID: 39008024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy Outcomes After Exposure to Certolizumab Pegol: Updated Results From a Pharmacovigilance Safety Database.
    Clowse MEB; Scheuerle AE; Chambers C; Afzali A; Kimball AB; Cush JJ; Cooney M; Shaughnessy L; Vanderkelen M; Förger F
    Arthritis Rheumatol; 2018 Sep; 70(9):1399-1407. PubMed ID: 29623679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review and meta-analyses of pregnancy and fetal outcomes in women with multiple sclerosis: a contribution from the IMI2 ConcePTION project.
    Lopez-Leon S; Geissbühler Y; Sabidó M; Turkson M; Wahlich C; Morris JK
    J Neurol; 2020 Sep; 267(9):2721-2731. PubMed ID: 32444984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Olanzapine in pregnancy and breastfeeding: a review of data from global safety surveillance.
    Brunner E; Falk DM; Jones M; Dey DK; Shatapathy CC
    BMC Pharmacol Toxicol; 2013 Aug; 14():38. PubMed ID: 23902726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of infants exposed to olanzapine during breastfeeding.
    Gilad O; Merlob P; Stahl B; Klinger G
    Breastfeed Med; 2011 Apr; 6(2):55-8. PubMed ID: 21034242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use and safety of disease-modifying therapy in pregnant women with multiple sclerosis.
    MacDonald SC; McElrath TF; Hernández-Díaz S
    Pharmacoepidemiol Drug Saf; 2019 Apr; 28(4):556-560. PubMed ID: 30834654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregnancy outcomes of women with multiple sclerosis treated with ocrelizumab in Canada: A descriptive analysis of real-world data.
    Gitman V; Stavropoulos A; Saenz V; Pasquarelli N; Zecevic D; Devonshire V
    Mult Scler Relat Disord; 2022 Jun; 62():103792. PubMed ID: 35452964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term use of glatiramer acetate by 11 pregnant women with multiple sclerosis: a retrospective, multicentre case series.
    Fragoso YD; Finkelsztejn A; Kaimen-Maciel DR; Grzesiuk AK; Gallina AS; Lopes J; Morales NM; Alves-Leon SV; de Almeida SM
    CNS Drugs; 2010 Nov; 24(11):969-76. PubMed ID: 20806993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.